Press Release for The Changing Face of Addiction VIRTUAL Summit

Join us for an enlightening and transformative experience at the Changing Face of Addiction Virtual Summit, where we bring together leading experts, inspiring advocates, and courageous individuals who are redefining the journey of addiction recovery. https://www.eventbrite.com/e/changing-face-of-addiction-virtual-summit-tickets-925342693907?aff=oddtdtcreator

DELRAY BEACH, FL / ACCESSWIRE / September 19, 2024 / This dynamic online event is designed to challenge outdated perceptions and shine a light on the multifaceted nature of addiction in today’s world.

Immerse yourself in a series of powerful talks, interactive workshops, and real-life stories that highlight innovative approaches to treatment, the importance of mental health, and the role of community and support systems. Discover cutting-edge research, holistic recovery strategies, and the latest advancements in addiction therapy that cater to the diverse needs of those affected.

Whether you’re in recovery, supporting a loved one, or a professional in the field, the Changing Face of Addiction Virtual Summit offers valuable insights, practical tools, and a supportive network to help you navigate the complexities of addiction. Together, we can break the stigma, foster resilience, and create a brighter, healthier future.

Don’t miss this opportunity to be part of a movement that is changing lives and reshaping the conversation around addiction.

Contact:

Adrienne Tichy,
561-376-5682,
https://thechangingfaceofaddiction.com

SOURCE: Recovery Comes Home

View the original press release on accesswire.com

Staff

Recent Posts

The Power of Tracking: New Preliminary Data Underscores How MyFitnessPal Supports Weight Management Goals

Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…

1 hour ago

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

4 hours ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

4 hours ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

4 hours ago